Related Experiment Videos
Intraoperative parathyroid hormone testing: what have we learned?
Matthew D Proctor1, Robert A Sofferman
1Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Vermont College of Medicine, Burlington, Vermont 05421, USA.
The Laryngoscope
|April 3, 2003
Summary
Intraoperative intact parathyroid hormone (iPTH) assays accurately predict hyperparathyroidism treatment success, especially for primary cases. A 50% iPTH drop indicates a successful parathyroid surgery outcome.
Area of Science:
- Endocrinology
- Surgical Oncology
- Medical Diagnostics
Background:
- Hyperparathyroidism management relies on accurate assessment of parathyroid tissue removal.
- Intraoperative intact parathyroid hormone (iPTH) assays offer real-time feedback on surgical success.
Purpose of the Study:
- To evaluate the efficacy of intraoperative iPTH assays in predicting the resolution of hyperparathyroidism.
- To review surgical outcomes in relation to intraoperative iPTH measurements.
Main Methods:
- Retrospective review of 107 parathyroidectomies performed by a single surgeon.
- Inclusion of patients with primary, secondary, and tertiary hyperparathyroidism.
- Analysis of intraoperative iPTH levels at 10 and 15 minutes post-excision.
Main Results:
- Overall success rate of 93.4% across all hyperparathyroidism types.
- Success rate of 95.7% for primary hyperparathyroidism.
- A 50% decrease in iPTH post-excision predicted successful treatment; normal postexcision iPTH did not always ensure cure.
Conclusions:
- Intraoperative iPTH assay is highly valuable for primary hyperparathyroidism, potentially replacing frozen-section analysis.
- The assay aids in confident limited resections, including complex cases like revision or concurrent thyroid surgery.
- While useful for secondary hyperparathyroidism, the assay may not guarantee long-term normocalcemia due to potential missed small glands.